April 15, 2014 / 4:35 AM / 4 years ago

BRIEF-Shenzhen Hepalink Pharma sees Q1 profit down 40-50 pct y/y

April 15 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd

* Says expects Q1 net profit down 40-50 percent y/y at 69.6-83.5 million yuan ($11.19-13.43 million) versus 139.1 million yuan previous year

Source text in Chinese: link.reuters.com/dek58v

Further company coverage: ($1 = 6.2191 Chinese Yuan) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below